Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs

Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs

Abstract The recent discovery of clinically significant data, alongside novel physiological and pathological occurrences surrounding sacubitril/valsartan (Sac/Val) beyond its approved indications, necessitates an urgent reevaluation of its underlying mechanism of action. In the present investigation...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjuan Wei, Guangsen Xu, Jiaer Gao, Guiyun Wang, Ye Wang, Caiyan Li, Junwei Zheng, Huiying Lu, Yunyan Lu, Kun Wang, Hongtao Xu, Cong Wang, Xuebo Pan
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Cardiovascular Diabetology
Subjects:
Sacubitril/Valsartan
Fibroblast growth factor 21
Peroxisome proliferation-activated receptor alpha
Peroxisome proliferation-activated receptor gamma
Myocardial infarction
Online Access:https://doi.org/10.1186/s12933-025-02627-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12933-025-02627-6

Similar Items